Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 12:35:04 UTC
Update Date2021-09-26 23:07:09 UTC
HMDB IDHMDB0253735
Secondary Accession NumbersNone
Metabolite Identification
Common NameN-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide
DescriptionN-(1-{4-[(2,4-dimethoxyphenyl)methyl]-5-(2-phenylethyl)-4H-1,2,4-triazol-3-yl}-2-(1H-indol-3-yl)ethyl)pyridine-2-carboximidic acid belongs to the class of organic compounds known as dimethoxybenzenes. These are organic aromatic compounds containing a monocyclic benzene moiety carrying exactly two methoxy groups. Based on a literature review very few articles have been published on N-(1-{4-[(2,4-dimethoxyphenyl)methyl]-5-(2-phenylethyl)-4H-1,2,4-triazol-3-yl}-2-(1H-indol-3-yl)ethyl)pyridine-2-carboximidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-[1-[4-[(2,4-dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1h-indol-3-yl)ethyl]pyridine-2-carboxamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
N-(1-{4-[(2,4-dimethoxyphenyl)methyl]-5-(2-phenylethyl)-4H-1,2,4-triazol-3-yl}-2-(1H-indol-3-yl)ethyl)pyridine-2-carboximidateGenerator
Chemical FormulaC35H34N6O3
Average Molecular Weight586.696
Monoisotopic Molecular Weight586.269238979
IUPAC NameN-(1-{4-[(2,4-dimethoxyphenyl)methyl]-5-(2-phenylethyl)-4H-1,2,4-triazol-3-yl}-2-(1H-indol-3-yl)ethyl)pyridine-2-carboxamide
Traditional NameN-(1-{4-[(2,4-dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl}-2-(1H-indol-3-yl)ethyl)pyridine-2-carboxamide
CAS Registry NumberNot Available
SMILES
COC1=CC(OC)=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CNC3=CC=CC=C23)NC(=O)C2=CC=CC=N2)C=C1
InChI Identifier
InChI=1S/C35H34N6O3/c1-43-27-17-16-25(32(21-27)44-2)23-41-33(18-15-24-10-4-3-5-11-24)39-40-34(41)31(38-35(42)30-14-8-9-19-36-30)20-26-22-37-29-13-7-6-12-28(26)29/h3-14,16-17,19,21-22,31,37H,15,18,20,23H2,1-2H3,(H,38,42)
InChI KeyUMGBPWZCCHVQAY-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dimethoxybenzenes. These are organic aromatic compounds containing a monocyclic benzene moiety carrying exactly two methoxy groups.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassMethoxybenzenes
Direct ParentDimethoxybenzenes
Alternative Parents
Substituents
  • M-dimethoxybenzene
  • Dimethoxybenzene
  • 3-alkylindole
  • Indole
  • Indole or derivatives
  • Pyridinecarboxamide
  • Pyridine carboxylic acid or derivatives
  • 2-heteroaryl carboxamide
  • Phenoxy compound
  • Anisole
  • Phenol ether
  • Alkyl aryl ether
  • Pyridine
  • Substituted pyrrole
  • Azole
  • Heteroaromatic compound
  • Pyrrole
  • 1,2,4-triazole
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Azacycle
  • Ether
  • Carboxylic acid derivative
  • Organoheterocyclic compound
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organonitrogen compound
  • Organic oxide
  • Organopnictogen compound
  • Organic nitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP5.11ALOGPS
logP5.29ChemAxon
logS-5.8ALOGPS
pKa (Strongest Acidic)12.1ChemAxon
pKa (Strongest Basic)2.41ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area106.95 ŲChemAxon
Rotatable Bond Count12ChemAxon
Refractivity171.01 m³·mol⁻¹ChemAxon
Polarizability64.04 ųChemAxon
Number of Rings6ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-263.90230932474
DeepCCS[M+Na]+238.74530932474
AllCCS[M+H]+243.432859911
AllCCS[M+H-H2O]+242.132859911
AllCCS[M+NH4]+244.632859911
AllCCS[M+Na]+245.032859911
AllCCS[M-H]-228.332859911
AllCCS[M+Na-2H]-229.432859911
AllCCS[M+HCOO]-230.832859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamideCOC1=CC(OC)=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CNC3=CC=CC=C23)NC(=O)C2=CC=CC=N2)C=C16409.6Standard polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamideCOC1=CC(OC)=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CNC3=CC=CC=C23)NC(=O)C2=CC=CC=N2)C=C14203.1Standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamideCOC1=CC(OC)=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CNC3=CC=CC=C23)NC(=O)C2=CC=CC=N2)C=C15347.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,1TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)NC(=O)C2=CC=CC=N2)C(OC)=C15139.6Semi standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,1TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)NC(=O)C2=CC=CC=N2)C(OC)=C14496.8Standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,1TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)NC(=O)C2=CC=CC=N2)C(OC)=C16841.3Standard polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,1TMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)C2=CC=CC=N2)[Si](C)(C)C)C(OC)=C15043.0Semi standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,1TMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)C2=CC=CC=N2)[Si](C)(C)C)C(OC)=C14533.0Standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,1TMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)C2=CC=CC=N2)[Si](C)(C)C)C(OC)=C16741.0Standard polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,2TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)N(C(=O)C2=CC=CC=N2)[Si](C)(C)C)C(OC)=C15007.4Semi standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,2TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)N(C(=O)C2=CC=CC=N2)[Si](C)(C)C)C(OC)=C14350.0Standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,2TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)N(C(=O)C2=CC=CC=N2)[Si](C)(C)C)C(OC)=C16322.3Standard polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,1TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)NC(=O)C2=CC=CC=N2)C(OC)=C15273.2Semi standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,1TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)NC(=O)C2=CC=CC=N2)C(OC)=C14597.5Standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,1TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)NC(=O)C2=CC=CC=N2)C(OC)=C16803.0Standard polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,1TBDMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)C2=CC=CC=N2)[Si](C)(C)C(C)(C)C)C(OC)=C15269.8Semi standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,1TBDMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)C2=CC=CC=N2)[Si](C)(C)C(C)(C)C)C(OC)=C14671.7Standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,1TBDMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)C2=CC=CC=N2)[Si](C)(C)C(C)(C)C)C(OC)=C16669.3Standard polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,2TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)N(C(=O)C2=CC=CC=N2)[Si](C)(C)C(C)(C)C)C(OC)=C15356.2Semi standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,2TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)N(C(=O)C2=CC=CC=N2)[Si](C)(C)C(C)(C)C)C(OC)=C14583.4Standard non polar33892256
N-[1-[4-[(2,4-Dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide,2TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)N(C(=O)C2=CC=CC=N2)[Si](C)(C)C(C)(C)C)C(OC)=C16284.9Standard polar33892256
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID21378475
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound53394052
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]